Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The insulin-like growth factor (IGF) system has been implicated in tumor growth, invasion, and metastasis. However, reports on the IGF-1 receptor (IGF-1R) based on radioimmunoassays are conflicting, and its prognostic implications in non-small-cell lung cancer (NSCLC) are still controversial. Methods: Seventy-one paraffin-embedded tissue sections from stage I NSCLC patients were stained using a mouse monoclonal antibody against human IGF-1R. Results: The intensity and frequency of IGF-1R expression on the membrane and cytoplasm of cancer cells was evaluated and scored using a semiquantitative system. IGF-1R expression was detected in nine of 71 (12.7%) cases. No significant relationship was found between clinical/histopathological parameters and IGF-1R expression. None of the patients whose tumor expressed IGF-1R had experienced distant metastasis or cancer-related death, although the difference did not reach statistical significance. Conclusions: We conclude that IGF-1R expression may not be a major prognostic factor for stage I NSCLC.
Abstract
Background/Aims: The insulin-like growth factor (IGF) system has been implicated in tumor growth, invasion, and metastasis. However, reports on the IGF-1 receptor (IGF-1R) based on radioimmunoassays are conflicting, and its prognostic implications in non-small-cell lung cancer (NSCLC) are still controversial. Methods: Seventy-one paraffin-embedded tissue sections from stage I NSCLC patients were stained using a mouse monoclonal antibody against human IGF-1R. Results: The intensity and frequency of IGF-1R expression on the membrane and cytoplasm of cancer cells was evaluated and scored using a semiquantitative system. IGF-1R expression was detected in nine of 71 (12.7%) cases. No significant relationship was found between clinical/histopathological parameters and IGF-1R expression. None of the patients whose tumor expressed IGF-1R had experienced distant metastasis or cancer-related death, although the difference did not reach statistical significance. Conclusions: We conclude that IGF-1R expression may not be a major prognostic factor for stage I NSCLC.
참고문헌 (25)
- Greenlee RT, "Cancer statistics, 2001", Ca-A Cancer Journal for Clinicians, 51, pp.15~36 (2001)
- Ward CW, "The three dimentional structure of the type I insulin-like growth factor receptor", Journal of Clinical Pathology - Molecular Pathology, 54, pp.125~132 (2001)
- Blakesley VA, "Role of the IGF-I receptor in mutagenesis and tumor promotion", JOURNAL OF ENDOCRINOLOGY, 152, pp.339~344 (1997)
- Baserga R, "The IGF-1 receptor in cancer biology", INTERNATIONAL JOURNAL OF CANCER, 107, pp.873~877 (2003)
- Yu H, "Role of the insulin-like growth factor family in cancer development and progression", Journal of the National Cancer Institute, 92, pp.1472~1489 (2000)
- Rocha RL, "Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival", CLINICAL CANCER RESEARCH, 3, pp.103~109 (1997)
- Turner BC, "Insulin-like growth factor-1 receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation", CANCER RESEARCH, 57, pp.3079~3083 (1997)
- Reinmuth N, "Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cance", CLINICAL CANCER RESEARCH, 8, pp.3259~3269 (2002)
- Tennant MK, "Protein and messenger ribonucleic acid (mRNA) for the type I insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium", Journal of Clinical Endocrinology and Metabolism, 81, pp.3774~3782 (1996)
- Happerfield LC, "The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue", JOURNAL OF PATHOLOGY, 183, pp.412~417 (1997)
- Chott A, "Tyrosin kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor", AMERICAN JOURNAL OF PATHOLOGY, 155, pp.1271~1279 (1999)
- Schnarr B, "Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer", INTERNATIONAL JOURNAL OF CANCER, 89, pp.506~513 (2000)
- Damon SE, "Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells", Endocrinology, 142, pp.21~27 (2001)
- Jacobs TW, "Specificity of Hercep Test in determing HER-2", neu status of breast cancers sing the United States Food and Drug Administration-approved scoring system, 1999, pp.17, 1983~1987
- Quinn KA, "Insulin-like growth factor expression in human cancer cell lines", JOURNAL OF BIOLOGICAL CHEMISTRY, 271, pp.11477~11483 (1996)
- Furstenberger G, "Insulin-like growth factors and cancer", Lancet Oncology, 3, pp.298~302 (2002)
- Mauro L, "Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression", JOURNAL OF CELLULAR PHYSIOLOGY, 194, pp.108~116 (2003)
- Rocha RL, "Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival", CLINICAL CANCER RESEARCH, 3, pp.103~109 (1997)
- Turner BC, "Insulin-like growth factor-1 receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation", CANCER RESEARCH, 57, pp.3079~3083 (1997)
- Resnik JL, "Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer", CANCER RESEARCH, 58, pp.1159~1164 (1998)
- Ahlén J, "Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma", CLINICAL CANCER RESEARCH, 11, pp.206~216 (2005)
- All-Ericsson C, "Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target", Investigative Ophthalmology and Visual Science, 43, pp.1~8 (2002)
- Hakam A, "Expression of insulin-like growth factor-1 receptor in human colorectal cancer", HUMAN PATHOLOGY, 30, pp.1128~1133 (1999)
- Baserga R, "The insulin-like growth factor I receptor: a key to tumor growth?", CANCER RESEARCH, 55, pp.249~252 (1995)
- Playford MP, "Insulin-like growth factor 1 regulates the location, stability and transcriptional activity of ß-catenin", Proceedings of the National Academy of Sciences of the United States of America, 97, pp.12103~12108 (2000)